US10806X1028
US10806X1028
BridgeBio Pharma, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 502.076.000 | 221.902.000 | 126.3% |
| Cost of Revenue | 20.962.000 | 3.878.000 | 440.5% |
| Gross Profit | 481.114.000 | 218.024.000 | 120.7% |
| 983.178.000 | 795.392.000 | 23.6% | |
| Operating Income | -502.064.000 | -577.368.000 | 13.0% |
| Pretax Income | -732.503.000 | -542.194.000 | 35.1% |
| Net Income Common Stockholders | -724.931.000 | -535.762.000 | 35.3% |
| -- | -- | -- | |
| -- | -- | -- |